Home » Topics » Disease categories and therapies » Immune

Immune
RSS

SciClone's Zadaxin now available in Italy

May 31, 2000

L-Glu-L-Trp analogues with advantages over parent compound

May 29, 2000

Use of verteporfin for improving xenograft transplant survival

May 26, 2000

Chiron's Fluad influenza vaccine approved under E.U. mutual recognition procedure

May 25, 2000

Isotechnika's new immunosuppressive drug successfully completes phase Ia

May 25, 2000

SERP-1: potential synergy with ciclosporin indicated by preclinical results

May 22, 2000

Targeted immunosuppression of alloreactive cells achieved with OX-40 immunotoxins

May 22, 2000

C220, a novel chimeric anti-CD40 MAb, prolongs renal allograft survival in primates

May 22, 2000

Orally bioavailable modified anti-ICAM-1 antisense oligo and effects in rat kidney transplant models

May 22, 2000

BioSante announces positive preclinical data on new vaccine adjuvant and delivery system

May 22, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...